Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02587962
Title Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Medivir
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
UCLA Dept of Medicine-Hematology/Oncology Santa Monica California 90404 United States Details
Mid Florida Hematology and Oncology Center Orange City Florida 32763 United States Details
The Sidney Kimmel Comprehensive Cancer Center at John Hopkins Baltimore Maryland 21287 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Thomas Jefferson University Sidney Kimmel Cancer Center Philadelphia Pennsylvania 19107 United States Details
Mary Crowley Cancer Research Dallas Texas 75251 United States Details
MD Anderson Cancer Center, The University of Texas Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field